William Blythe
Park Place advised the management team of William Blythe, an Accrington-based speciality chemicals manufacturer, on their £30m carve-out MBO from Synthomer plc with funding from H2 Equity Partners and HSBC.
Founded in 1845, William Blythe is a £50m revenue global leader in the manufacture of speciality inorganic derivatives of elements such as tin, iodine, copper, zinc and tungsten that form critical inputs to products across a range of industries including healthcare, electronics, automotive, construction products, energy and consumer goods. Key product segments include flame retardants, thermal stabilisers, absorbents and catalysts.
Park Place assisted the management team through the process of the carve-out from its PLC parent and helped establish their ongoing incentive structure to ensure clear shareholder alignment with the incoming investor.
David Crossley, Managing Director of William Blythe, commented “The team at Park Place provided valuable counsel throughout the process of the MBO and gave us great comfort that our position was properly considered at the appropriate points. This was our first collaboration with Park Place and it won’t be the last.”
Richard Firth, who led the advice to management, added “William Blythe benefits from market-leading in-house R&D capabilities and deep experience in formulating chemicals. In H2, the team have partnered with a funder that has demonstrated its conviction and so they are well set to execute their ambitious growth strategy.”
